New! Sign up for our free email newsletter.
Science News
from research organizations

New gene mutation associated with defective DNA repair and Fanconi anemia

Date:
July 10, 2017
Source:
JCI Journals
Summary:
Fanconi anemia is a rare genetic disease characterized by hematologic symptoms and high cancer risk. Mutations in nearly 20 different genes have been identified in patients with Fanconi anemia. Medical researchers now reveal a new Fanconi anemia gene, RFWD3, that is involved in complex DNA repair processes and may also play a relevant role in cancer risk.
Share:
FULL STORY

Fanconi anemia is a rare genetic disease characterized by hematologic symptoms that include low platelet count and unusually large red blood cells. Mutations in nearly 20 genes have been identified as causative for Fanconi anemia, all of which encode proteins involved in DNA repair mechanisms. The failure to repair DNA is also considered the source of increased cancer risk in individuals with Fanconi anemia. Ongoing efforts to identify additional genes and pathways linked to this disease may also reveal potential susceptibility genes for hereditary cancers.

This week in the JCI, a team led by Detlev Schindler at the University of Wurzburg describes classical Fanconi anemia-like symptoms in a 12 year-old individual without mutations in any known Fanconi anemia genes. Sequencing of this individual's genome detected missense mutations in both alleles of the gene RFWD3, which encodes an enzyme that helps target other proteins for degradation. This patient's cells were more sensitive to chromosome breakage and showed other indicators of increased susceptibility to DNA damage compared to cells from healthy individuals. Cells lacking RFWD3 or harboring the patient's mutation showed similar DNA repair defects, which were rescued by expression of wild-type RFWD3. Moreover, RFWD3-deficient mice exhibited a phenotype that resembled other mouse models of Fanconi anemia. Together, these findings support the identification of RFWD3 as a Fanconi anemia gene.

Schindler and collaborators further describe the mechanisms by which RFWD3 mediates DNA repair in two recently-published studies in Molecular Cell. Future explorations of this enzyme may reveal its importance as a biomarker or therapeutic target in Fanconi anemia, cancer, or other human disease.


Story Source:

Materials provided by JCI Journals. Note: Content may be edited for style and length.


Journal References:

  1. Kerstin Knies, Shojiro Inano, María J. Ramírez, Masamichi Ishiai, Jordi Surrallés, Minoru Takata, Detlev Schindler. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia. Journal of Clinical Investigation, 2017; DOI: 10.1172/JCI92069
  2. Laura Feeney, Ivan M. Muñoz, Christophe Lachaud, Rachel Toth, Paul L. Appleton, Detlev Schindler, John Rouse. RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health. Molecular Cell, 2017; 66 (5): 610 DOI: 10.1016/j.molcel.2017.04.021

Cite This Page:

JCI Journals. "New gene mutation associated with defective DNA repair and Fanconi anemia." ScienceDaily. ScienceDaily, 10 July 2017. <www.sciencedaily.com/releases/2017/07/170710161001.htm>.
JCI Journals. (2017, July 10). New gene mutation associated with defective DNA repair and Fanconi anemia. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2017/07/170710161001.htm
JCI Journals. "New gene mutation associated with defective DNA repair and Fanconi anemia." ScienceDaily. www.sciencedaily.com/releases/2017/07/170710161001.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES